IP103 Pill — BROWN CAPSULE, 21mm — Gabapentin

No photo available

Imprint	IP103
Colour	BROWN
Shape	CAPSULE
Size	21
Strength	GABAPENTIN 400 mg
Dosage form	Capsule
Manufacturer	Keltman Pharmaceuticals Inc.
NDC	68387-404
Schedule	—
Availability	—
Ingredients	GABAPENTIN[GABAPENTIN]

What does this imprint mean?

The imprint "IP103" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Gabapentin

Uses and warnings

Major Warnings: - Suicidal Behavior: AEDs including gabapentin approximately double the risk of suicidal thoughts/behavior, affecting about 1 in 500 patients. Early warning signs require immediate healthcare provider notification. - Pediatric Neuropsychiatric Effects: In children 3-12 years, gabapentin causes emotional lability (6%), hostility (5.2%), hyperkinesia (4.7%), and thought disorder (1.7%). - Withdrawal Risk: Abrupt discontinuation can cause severe seizures. Gradual tapering over minimum 1 week is required. - Hypersensitivity Reaction: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) reported, presenting with fever, rash, and lymphadenopathy. ---

Gabapentin treats two main conditions: Postherpetic Neuralgia: "Gabapentin is indicated for the management of postherpetic neuralgia in adults." Epilepsy: The medication serves as "adjunctive therapy in the treatment of partial seizures" in patients over 12 years and in pediatric patients ages 3-12 years. ---

Read the full drug profile →